Yeji Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yeji Lim has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Choon Ok Kim
Department of Clinical Pharmacology, Severance Hospital, Yonsei University Health System, Seoul 03722, Republic of Korea
2 shared publications - Hyeonsoo Park
Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Korea
2 shared publications - Min Soo Park
Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
2 shared publications - Sukyong Yoon
Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
2 shared publications - Woo Yul Lee
Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Korea
2 shared publications - Anhye Kim
Department of Clinical Pharmacology and Therapeutics, CHA University Bundang Medical Center, Seongnam, Republic of Korea.
1 shared publication
Latest Publications
- 30 April 2023
- Published by Asia Culture Academy of Incorporated Association in The Journal of Humanities and Social Sciences
- Vol. 14 (2) , 323-334
Changes in the Perception of Pre-service Teachers Who Experienced Logic and Essay in Early Childhood Education
학술논문검색사이트 KISS는 학술논문,연구논문,연구자료,학술지 등 다양한 자료를 서비스하며, 주제별, 등재별, 인용지수, 인기논문, 이슈논문 등 다양한 키워드의 논문을 제공하여 빠른 학술검색 및 인용이 가능하도록 서비스합니다.
- 30 April 2023
- Published by Asia Culture Academy of Incorporated Association in The Journal of Humanities and Social Sciences
- Vol. 14 (2) , 323-334
Changes in the Perception of Pre-service Teachers Who Experienced Logic and Essay in Early Childhood Education
학술논문검색사이트 KISS는 학술논문,연구논문,연구자료,학술지 등 다양한 자료를 서비스하며, 주제별, 등재별, 인용지수, 인기논문, 이슈논문 등 다양한 키워드의 논문을 제공하여 빠른 학술검색 및 인용이 가능하도록 서비스합니다.
- 30 April 2023
- Published by Korean Association For Learner-Centered Curriculum And Instruction in Korean Association For Learner-Centered Curriculum And Instruction
- Vol. 23 (8) , 229-245
Early childhood teachers' experience of literature education for young children in play-centered curriculum
Objectives The purpose of this study is to explore the experience of how early childhood teachers conduct literature education for young children in a play-centered curriculum. Methods The participants in this study were 20 early childhood teachers working at an early childhood education institution in Gyeonggi-do, who were taking the 「Literature Education for Young children」 course at the Graduate School of Education of A University. The participants collected reflective journals about what they experienced and felt about literature education for young children while implementing the play-centered curriculum, analyzed the data, and then qualitatively analyzed it. Results As a result of analyzing the experience of literature education for young children in the play-centered curriculum, firstly, the early childhood teachers supported the environment for early childhood literature in the play-centered curriculum. Second, early childhood teachers made efforts to conduct literature education for young children while operating a play-centered curriculum. Depending on the teacher's personal background and the situation of the institution, the importance of literature education in the curriculum varied, and literature education was carried out independently from the curriculum, or play and literature education for young children were linked or operated in harmony. Conclusions Based on the results of this study, early childhood teachers' experiences in literature education for young children and their thoughts were examined. This study has significance in providing the necessary basis for early childhood teachers to seek ways to implement substantial literature education for young children and to promote the quality improvement of literature education for young children in the field.
- 30 April 2023
- Published by Korean Association For Learner-Centered Curriculum And Instruction in Korean Association For Learner-Centered Curriculum And Instruction
- Vol. 23 (8) , 229-245
Early childhood teachers' experience of literature education for young children in play-centered curriculum
Objectives The purpose of this study is to explore the experience of how early childhood teachers conduct literature education for young children in a play-centered curriculum. Methods The participants in this study were 20 early childhood teachers working at an early childhood education institution in Gyeonggi-do, who were taking the 「Literature Education for Young children」 course at the Graduate School of Education of A University. The participants collected reflective journals about what they experienced and felt about literature education for young children while implementing the play-centered curriculum, analyzed the data, and then qualitatively analyzed it. Results As a result of analyzing the experience of literature education for young children in the play-centered curriculum, firstly, the early childhood teachers supported the environment for early childhood literature in the play-centered curriculum. Second, early childhood teachers made efforts to conduct literature education for young children while operating a play-centered curriculum. Depending on the teacher's personal background and the situation of the institution, the importance of literature education in the curriculum varied, and literature education was carried out independently from the curriculum, or play and literature education for young children were linked or operated in harmony. Conclusions Based on the results of this study, early childhood teachers' experiences in literature education for young children and their thoughts were examined. This study has significance in providing the necessary basis for early childhood teachers to seek ways to implement substantial literature education for young children and to promote the quality improvement of literature education for young children in the field.
- Open Access
- 1 January 2023
- Published by XMLink in Translational and Clinical Pharmacology
- Vol. 31 (4) , 226-237
Pharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal function
Park M, et al. Transl Clin Pharmacol. 2023 Dec;31(4):226-237. https://doi.org/10.12793/tcp.2023.31.e20
- 1 January 2023
- Published by XMLink in Translational and Clinical Pharmacology
- Vol. 31 (4) , 226-237
Open AccessPharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal function
Park M, et al. Transl Clin Pharmacol. 2023 Dec;31(4):226-237. https://doi.org/10.12793/tcp.2023.31.e20
- Open Access
- 1 January 2020
- Published by Korean Society for Clinical Pharmacology and Therapeutics in Translational and Clinical Pharmacology
- Vol. 28 (3) , 136-146
Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
Park H, et al. Transl Clin Pharmacol. 2020 Sep;28:e16. /Synapse/10.12793/tcp.2020.28.e16
- 1 January 2020
- Published by Korean Society for Clinical Pharmacology and Therapeutics in Translational and Clinical Pharmacology
- Vol. 28 (3) , 136-146
Open AccessPharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
Park H, et al. Transl Clin Pharmacol. 2020 Sep;28:e16. /Synapse/10.12793/tcp.2020.28.e16
- Open Access
- 1 January 2020
- Published by Korean Society for Clinical Pharmacology and Therapeutics in Translational and Clinical Pharmacology
- Vol. 28 (1) , 55-65
Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects
Lee WY, et al. Transl Clin Pharmacol. 2020 Mar;28:e5. /Synapse/10.12793/tcp.2020.28.e5
- 1 January 2020
- Published by Korean Society for Clinical Pharmacology and Therapeutics in Translational and Clinical Pharmacology
- Vol. 28 (1) , 55-65
Open AccessEvaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects
Lee WY, et al. Transl Clin Pharmacol. 2020 Mar;28:e5. /Synapse/10.12793/tcp.2020.28.e5
- Open Access
- 1 July 2019
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 13, 2533-2542
Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects
Purpose: Hypertension and dyslipidemia are major risk factors for cardiovascular diseases, and reduction of cardiovascular risks can be achieved by combining antihypertensive therapy with statins. The objective of this study was to evaluate the pharmacokinetic interaction between telmisartan/amlodipine fixed dose combination and rosuvastatin in healthy Korean male volunteers. Patients and methods: An open-label, two-cohort, multiple-dose, single-sequence crossover study was conducted in healthy male subjects. In Cohort 1, the subjects were administered one tablet of telmisartan/amlodipine 80 mg/5 mg once daily for 14 days with or without one tablet of rosuvastatin 20 mg once daily. In Cohort 2, the subjects were administered one tablet of rosuvastatin 20 mg once daily for 14 days with or without one tablet of telmisartan/amlodipine 80 mg/5 mg once daily. Serial blood samples were collected up to 24 hrs post-dose on the 9th and 14th days in Cohort 1 and on the 5th and 14th days in Cohort 2. Plasma drug concentrations were measured by liquid chromatography/tandem mass spectrometry. Pharmacokinetic parameters, including maximum plasma concentration at steady state (Cmax,ss) and area under the plasma concentration versus time curve over dosing interval (AUCτ,ss), were determined by non-compartmental analysis. The geometric least-square mean (GLSM) ratios and associated 90% confidence intervals (CIs) of log-transformed Cmax,ss and AUCτ,ss for separate or concurrent therapy were calculated to evaluate pharmacokinetic interactions. Results: Thirty-eight subjects from Cohort 1 and nineteen subjects from Cohort 2 completed the study. The GLSM ratios and 90% CIs of Cmax,ss and AUCτ,ss, were 0.9829 (0.8334–1.1590) and 1.0003 (0.9342–1.0710) for telmisartan; 0.9908 (0.9602–1.0223) and 1.0081 (0.9758–1.0413) for amlodipine; and 2.2762 (2.0113–2.5758) and 1.3261 (1.2385–1.4198) for rosuvastatin, respectively. Conclusion: The pharmacokinetic parameters of telmisartan/amlodipine, but not rosuvastatin, met the pharmacokinetic equivalent criteria. The increase in systemic exposure to rosuvastatin caused by telmisartan/amlodipine co-administration would not be clinically significant in practice. Nevertheless, an appropriately designed two-sequence crossover study is needed to confirm the results of this study.
- 1 July 2019
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 13, 2533-2542
Open AccessPharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects
Purpose: Hypertension and dyslipidemia are major risk factors for cardiovascular diseases, and reduction of cardiovascular risks can be achieved by combining antihypertensive therapy with statins. The objective of this study was to evaluate the pharmacokinetic interaction between telmisartan/amlodipine fixed dose combination and rosuvastatin in healthy Korean male volunteers. Patients and methods: An open-label, two-cohort, multiple-dose, single-sequence crossover study was conducted in healthy male subjects. In Cohort 1, the subjects were administered one tablet of telmisartan/amlodipine 80 mg/5 mg once daily for 14 days with or without one tablet of rosuvastatin 20 mg once daily. In Cohort 2, the subjects were administered one tablet of rosuvastatin 20 mg once daily for 14 days with or without one tablet of telmisartan/amlodipine 80 mg/5 mg once daily. Serial blood samples were collected up to 24 hrs post-dose on the 9th and 14th days in Cohort 1 and on the 5th and 14th days in Cohort 2. Plasma drug concentrations were measured by liquid chromatography/tandem mass spectrometry. Pharmacokinetic parameters, including maximum plasma concentration at steady state (Cmax,ss) and area under the plasma concentration versus time curve over dosing interval (AUCτ,ss), were determined by non-compartmental analysis. The geometric least-square mean (GLSM) ratios and associated 90% confidence intervals (CIs) of log-transformed Cmax,ss and AUCτ,ss for separate or concurrent therapy were calculated to evaluate pharmacokinetic interactions. Results: Thirty-eight subjects from Cohort 1 and nineteen subjects from Cohort 2 completed the study. The GLSM ratios and 90% CIs of Cmax,ss and AUCτ,ss, were 0.9829 (0.8334–1.1590) and 1.0003 (0.9342–1.0710) for telmisartan; 0.9908 (0.9602–1.0223) and 1.0081 (0.9758–1.0413) for amlodipine; and 2.2762 (2.0113–2.5758) and 1.3261 (1.2385–1.4198) for rosuvastatin, respectively. Conclusion: The pharmacokinetic parameters of telmisartan/amlodipine, but not rosuvastatin, met the pharmacokinetic equivalent criteria. The increase in systemic exposure to rosuvastatin caused by telmisartan/amlodipine co-administration would not be clinically significant in practice. Nevertheless, an appropriately designed two-sequence crossover study is needed to confirm the results of this study.